The Drug Enforcement Administration this week proposed changing rules that govern the amount of prescription opioids that drug manufacturers can produce each year. The changes could sharply reduce the annual production of opioids, Reuters reports.
The Food and Drug Administration will host a public meeting April 17 on patient-focused drug development for opioid use disorder, in collaboration with the National Institute on Drug Abuse.
The acting chief of the Drug Enforcement Administration told the House Energy and Committee this week the agency is doing a better job of tracking the flow of opioid painkillers from manufacturers to pharmacies, The Washington Post reports.
A new study finds there are no significant differences between young adults who misuse prescription opioids and those who inject heroin, except for the amount of time they have used drugs.
Deaths from overdoses of prescription sedatives known as benzodiazepines—including Xanax and Valium—are on the rise, according to a report in the New England Journal of Medicine.
A new Justice Department task force will examine the role of drug manufacturers and distributors in the opioid crisis, Attorney General Jeff Sessions said this week.
Purdue Pharma, the maker of OxyContin, said it will no longer market the drug to doctors. The announcement comes in response to lawsuits that blame the company for helping to trigger the opioid crisis, CBS News reports.
